CoCo3 - Comprehensive Health Effects of Combined Contraceptives: a 12-month randomized, controlled, open-label trial of E4+DRSP, EE20μg+DRSP and DRSP-only

Status

Not yet recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-523359-71-00

Enrollment

156

Registered

2026-04-17

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Brief summary

12-month use of study preparation, endpoint visit

Interventions

DRUGSlinda 4 mg kalvopäällysteinen tabletti

DRUGDrovelis 3 mg/14.2 mg film-coated tablets

DRUGDaylette 0

DRUG02 mg / 3 mg tabletti

DRUGkalvopäällysteinen

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
12-month use of study preparation, endpoint visit	—

Outcome results

None listed

Source: EU CTIS · Data processed: Apr 18, 2026